Stock Events

Stock Events

Mineralys Therapeutics (MLYS) Q2 2023 Earnings

7AugExpected

Q4 2022

Q1 2023

Q2 2023

-1.74

-1.26

-0.79

-0.31

Details

Expected EPS

-0.72

Actual EPS

-0.31

Surprise EPS

0.41

Surprise Percent

+56.94%

Description

Mineralys Therapeutics (MLYS) has reported earnings of -0.31 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.